World-Leading Surgeon Professor J.P. Hong Appointed as CMO for MediThinQ, Pioneering Digital Microsurgery Innovations

MediThinQ Welcomes Professor J.P. Hong as Chief Medical Officer

MediThinQ, an emerging leader in the medical technology arena, has made headlines with its recent announcement of the appointment of Professor Joon-pio Hong as Chief Medical Officer. His inclusion is heralded as a significant endorsement for the company’s groundbreaking digital microsurgery platform, SHIYA 20, marking a key development in the field of innovative surgical technologies.

Who is Professor Joon-pio Hong?

Professor Joon-pio Hong is not just any surgeon; he is a globally recognized authority in reconstructive and super-microsurgery. Serving as the President of the World Society for Reconstructive Microsurgery and holding prestigious positions at both Asan Medical Center in South Korea and Georgetown University in the United States, he brings with him a wealth of experience and credibility. Professor Hong has dedicated his career to advancing surgical techniques and training surgeons on a global scale.

Having published numerous research articles and participating in intensive training programs worldwide, he has become a pivotal figure advocating for technological advancements in the surgical landscape. His firsthand experience with SHIYA 20 in live surgical settings has added significant validation, making his leadership at MediThinQ particularly impactful.

The SHIYA 20 Platform

The SHIYA 20 platform stands out as one of the earliest fully integrated systems for 3D digital microsurgery. It combines visualization, ergonomic design, and data capture into a unified platform centered around the needs of the surgeon. Over the past year, Prof. Hong has utilized this system extensively, affirming its capabilities in enhancing the surgical experience through its innovative features.

Describing the importance of the SHIYA 20, Professor Hong stated, "This system offers a range of low- to high-power magnification up to 20x, along with true 3D digital data and remarkable ergonomic flexibility. These elements are not mere conveniences; they are essential for ensuring safety and precision in microsurgery. SHIYA 20 delivers these needs in one platform, facilitating a more efficient, data-driven operating room that is ready for future challenges."

MediThinQ's Vision and Future Growth

Seungjoon Im, Founder and CEO of MediThinQ, highlighted that Professor Hong's appointment underscores their growing trust within the surgical community. His leadership will be instrumental in advancing SHIYA 20's role in modern surgical practices and guiding the expansion of their digital ecosystem. This ecosystem aims to support surgical education, collaboration, and AI-driven innovation in the industry.

The SHIYA 20 platform is renowned for its integration of various advanced technologies, such as a 3D digital microscope, an exoscope, and the SCOPEYE wearable visor. The amalgamation of these components offers improved clarity, ergonomics, and efficiency, creating a new benchmark for contemporary microsurgery.

MediThinQ is also accelerating its commercial expansion, recently establishing exclusive distribution agreements in Taiwan, Singapore, and Malaysia, alongside regulatory approvals that allow them to expand their presence into Mainland China through a partnership with Sinopharm.

Conclusion

The arrival of Professor Joon-pio Hong as CMO of MediThinQ signifies a new chapter in the evolution of surgical technology. His acknowledgment of SHIYA 20 not only validates its importance but also paves the way for a future where digital microsurgery becomes a standard practice, underpinned by enhanced surgical outcomes and a commitment to precision. With influential leaders like Prof. Hong at the helm, MediThinQ is well-positioned to lead the charge in revolutionizing the surgical landscape globally.